InvestorsHub Logo

Hypi

03/07/17 11:57 AM

#289361 RE: asmarterwookie #289359

Poor Volume and no options trading either says people have lost interest for the time being. Friday looks like the next catalyst as players might want in before the open on Monday. Though earnings are AH's. To be honest we need news to drive this over $1 and probably won't get it until Monday. Based on that scenario a .70-.75 close for the week would be good. I will be disappointed if we don't see some volume come into this stock in the afternoon.

Tough_to_make_money

03/07/17 12:06 PM

#289362 RE: asmarterwookie #289359

EOD as we all know by now

Will be the EOD. Ummm, if your asking me I'll defer until after lunch I'm not sure if crow or duck is on the menu. But we for sure will know after it is eaten. How we digest it will be known in the a.m. :)

biopharm

03/07/17 12:34 PM

#289365 RE: asmarterwookie #289359

EOD one day will be much higher ....hmmmm, especially when this Jersey boy below sees the full potential behind PS Targeting and all that will be discovered



"Jeff Boschwitz

Jeff Boschwitz, Ph.D., NMG consultant, is a healthcare executive with a strong scientific and business background. He has consistently developed and executed game-changing ideas to drive business to the next level of performance while improving health outcomes and reducing costs.

Dr. Boschwitz is well versed in strategic planning, growth strategy development, new product planning, due diligence for product licensing and commercialization strategy. He also has experience with post-merger integration planning, laboratory operations process re-engineering and improvements, and laboratory build-outs.

Prior to joining NMG, Dr. Boschwitz was Chief Operating Office of Personal Genome Diagnostics, a cancer genomics start-up spun out of Johns Hopkins University. He also served as Executive Vice President of Operations for PLUS Diagnostics, Vice President of Sales and Marketing for Orchid Cellmark and Director of Market Research, Planning, and Analysis for Quest Diagnostics.

Dr. Boschwitz has a B.S. In biology and Ph.D. In Immunology from Cornell University and completed his post-doctoral fellowship at Stanford University.

Dr. Boschwitz resides in New Jersey with his family."